Pulmonary Circulation (Apr 2022)

Right heart thrombi (RHT) and clot in transit with concomitant PE management: Approach and considerations

  • Akhil Khosla,
  • Hamid Mojibian,
  • Roland Assi,
  • Hossam Tantawy,
  • Inderjit Singh,
  • Jeffrey Pollak

DOI
https://doi.org/10.1002/pul2.12080
Journal volume & issue
Vol. 12, no. 2
pp. n/a – n/a

Abstract

Read online

Abstract Right heart thrombi (RHT) continues to pose a clinical dilemma for multiple specialties and is especially concerning when present with concomitant pulmonary embolism (PE). Patients with PE and RHT are at an increased risk of poor outcomes compared to PE without RHT. Although the exact incidence of RHT is unknown, the increasing use of point‐of‐care ultrasound may lead to an increased detection and frequency of RHT. There are multiple treatment strategies available for RHT, including anticoagulation, systemic thrombolysis, and endovascular and surgical therapies. Given that these treatment strategies involve multiple medical specialties, the management of RHT with concomitant PE can be complex. Currently, there is limited clinical data and guidelines on the treatment and management of RHT. We aim to provide a review on RHT with concomitant PE, including risk stratification, treatment considerations, and our approach to the management of RHT.

Keywords